Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay

Showing results (461-470 of 37,352) with videos related to

Pageof 3,736
Sort By:
Circulation|July 13, 2016
Is the Mortality Benefit With Empagliflozin in Type 2 Diabetes Mellitus Too Good To Be True?Sanjay Kaul
The Lancet. Oncology|March 1, 2016
Updated Canadian colorectal cancer screening guidelinesSanjay Tanday
Current Infectious Disease Reports|February 17, 2016
Pyomyositis in ChildrenSanjay Verma
Annals of the Academy of Medicine, Singapore|August 22, 2015
Re: An Alternative Diagnosis: Bartonella NeuroretinitisSanjay Srinivasan
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 6, 2015
One Small Step for Empagliflozin, One Giant Leap for DiabetologySanjay Kalra
The Journal of Medical Humanities|February 9, 2018
Unspoken PleaSanjay Bhandari
Journal of Atrial Fibrillation|May 13, 2017
Characterization of Left Atrial Tachyarrhythmias in Patients Following Atrial Fibrillation Ablation:Correlation of surface ECG with Intracardiac MappingSanjay Dixit
Journal of Atrial Fibrillation|May 13, 2017
Atrial Fibrillation Progression: New Insight in TheNatural History of This ArrhythmiaSanjay Dixit
Journal of Atrial Fibrillation|May 13, 2017
Is Isolation of Arrhythmogenic Pulmonary Veins Sufficient for the Long-term Efficacy of Atrial Fibrillation Ablation?Sanjay Dixit
Issues in Medical Ethics|December 13, 2005
SARS: infectious diseases, public health and medical ethicsSanjay Nagral
Pageof 3,736

Showing results (461-470 of 37,352) with videos related to

Sort By:
Pageof 3,736
Circulation|July 13, 2016
Is the Mortality Benefit With Empagliflozin in Type 2 Diabetes Mellitus Too Good To Be True?Sanjay Kaul
The Lancet. Oncology|March 1, 2016
Updated Canadian colorectal cancer screening guidelinesSanjay Tanday
Current Infectious Disease Reports|February 17, 2016
Pyomyositis in ChildrenSanjay Verma
Annals of the Academy of Medicine, Singapore|August 22, 2015
Re: An Alternative Diagnosis: Bartonella NeuroretinitisSanjay Srinivasan
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 6, 2015
One Small Step for Empagliflozin, One Giant Leap for DiabetologySanjay Kalra
The Journal of Medical Humanities|February 9, 2018
Unspoken PleaSanjay Bhandari
Journal of Atrial Fibrillation|May 13, 2017
Characterization of Left Atrial Tachyarrhythmias in Patients Following Atrial Fibrillation Ablation:Correlation of surface ECG with Intracardiac MappingSanjay Dixit
Journal of Atrial Fibrillation|May 13, 2017
Atrial Fibrillation Progression: New Insight in TheNatural History of This ArrhythmiaSanjay Dixit
Journal of Atrial Fibrillation|May 13, 2017
Is Isolation of Arrhythmogenic Pulmonary Veins Sufficient for the Long-term Efficacy of Atrial Fibrillation Ablation?Sanjay Dixit
Issues in Medical Ethics|December 13, 2005
SARS: infectious diseases, public health and medical ethicsSanjay Nagral
Pageof 3,736